A point mutation (E168Q) in the OLA1 gene is linked to apoptosis, preventing the formation of a complex with BRCA1 and BARD1, and is associated with poor outcomes in breast cancer [3]. The gene discussed is BRCA1; the disease is breast carcinoma.